Company overview
USCC
91370100614074047M
Id2
370000400001223
English Name
Qilu Antibiotics Pharmaceutical Co., Ltd.
Former names
齐鲁安替比奥制药有限公司
Chinese Name
齐鲁安替制药有限公司
Entity type
Limited Liability Company (Taiwan/HK/Macao – Mainland Joint Venture)
Authorized capital
¥31,927
Phone
+8653183128588
Representative
王勇进
Establishment date
29 May 1995
Country
China
Primary goods traded
| Data Source | HS Code | Description | Buyer | Buyer Country | Seller | Seller Country | ||
|---|---|---|---|---|---|---|---|---|
| 14 March 2025 | ID | 29419000 | Cefixime | PT Karunia Makmur Selaras | ID | Qilu Antibiotics Pharmaceutical Company Limited | $589,022.49 | |
| 19 February 2024 | ID | 29419000 | Cefixime | PT Karunia Makmur Selaras | ID | Qilu Antibiotics Pharmaceutical Company Limited | $542,100.00 | |
| 8 October 2018 | IN | 29411090 | Cefepime Hydrochloride Ip Non Sterile | Nectar Life Sciences Limited | IN | Qilu Antibiotics Pharmaceutical Company Limited | $504,000.00 | |
| 17 June 2025 | ID | 29419000 | Cefixime | PT Karunia Makmur Selaras | ID | Qilu Antibiotics Pharmaceutical Company Limited | $476,504.28 | |
| 18 April 2022 | IN | 29419090 | Sterile Cefepime For Injection (Sterile Mixture Of Cefepimehydrochloride And L Arginine) | Astral Steritech Private Limited | IN | Qilu Antibiotics Pharmaceutical Company Limited | $462,890.47 | |
| 7 March 2022 | IN | 29411090 | Ceftazidime For Injection Ip (Bulk Sterile) | Nectar Life Sciences Limited | IN | Qilu Antibiotics Pharmaceutical Company Limited | $437,500.00 | |
| 14 January 2025 | ID | 29419000 | Cefixime | PT Karunia Makmur Selaras | ID | Qilu Antibiotics Pharmaceutical Company Limited | $418,230.84 | |
| 23 April 2022 | IN | 29419090 | Cefepime Hcl Ip Non Sterile | Nectar Life Sciences Limited | IN | Qilu Antibiotics Pharmaceutical Company Limited | $416,000.00 | |
| 13 April 2022 | IN | 29419019 | Cefepime Hcl Ip Non Sterile I.P. | Aurobindo Pharma Limited | IN | Qilu Antibiotics Pharmaceutical Company Limited | $406,000.00 | |
| 25 April 2022 | IN | 29419019 | Cefepime Hcl Ip Non Sterile I.P. | Aurobindo Pharma Limited | IN | Qilu Antibiotics Pharmaceutical Company Limited | $406,000.00 |
| Partner | Type | Total Value | Percentage |
|---|---|---|---|
| PT Karunia Makmur Selaras | buyer | $8,111,152 | 37.66% |
| PT Dexa Medica | buyer | $5,659,639 | 26.28% |
| PT Bernofarm | buyer | $1,193,950 | 5.54% |
| PT Tatarasa Primatama | buyer | $236,970 | 1.10% |